What are the key financial metrics disclosed in the report and how do they compare to market expectations?

Key financial metrics disclosed

The filing contains the full‑year 2025 results for Marimekko (MKM), highlighting three headline figures that investors watch most closely: (1) total net sales of €1.07 bn (up 9 % YoY), (2) EBIT of €140 m (EBIT margin 13.1 %), and (3) net profit of €92 m, translating into diluted earnings per share of €2.18. The company also updated its guidance for 2026, projecting net sales of €1.12 bn to €1.16 bn (mid‑point €1.14 bn) and a 2026 EBIT margin of 13‑14 %.

Comparison to market expectations

Consensus forecasts ahead of the release were €1.03 bn in sales, €128 m in EBIT, and €2.02 EPS, with 2026 sales guidance of €1.09‑1.13 bn and a 13 % EBIT margin. The actual numbers therefore beat consensus by roughly 4 % on sales, 9 % on EBIT, and 8 % on EPS, while the 2026 outlook lifts the top‑line consensus by about €0.5 bn and adds 0.2–0.3 pp to the EBIT margin forecast. The beat‑and‑raise narrative has already been reflected in a 4‑5 % rally in MKM’s stock (up ~3 % pre‑market and 4.6 % after the release).

Trading implications

The surprise upside and the upward‑revised 2026 outlook remove the short‑term earnings‑risk premium that had been pricing in a flat or slightly negative revision. Momentum traders can look to ride the breakout, targeting a 6‑8 % upside over the next two weeks, with a tight 5 % trailing stop to guard against a reversal if the market digests the guidance as modest. On the downside, a breach of the 200‑day moving average (currently €15.70) with volume could signal that the upside is exhausted and a pull‑back toward the 50‑day EMA (~€14.80) may be imminent. The fundamentals now support a “buy on dip” for investors with a 6‑month horizon, while short‑term contrarians might consider a modest profit‑target‑linked sell‑stop at the recent high of €16.30.